McCarthy Asset Management’s Merck MRK Stock Holding History

McCarthy Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-360	Closed	-$30K	–	193
2022 Q1	$30K	Hold	360	–	–	0.02%	111
2021 Q4	$28K	Hold	360	–	–	0.02%	121
2021 Q3	$27K	Sell	360 -315	-47%	-$24K	0.02%	124
2021 Q2	$53K	Sell	675 -27	-4%	-$2.01K	0.04%	91
2021 Q1	$52K	Buy	+702	New	+$51.8K	0.04%	90

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

McCarthy Asset Management's MRK Position: Q2 2022 in Review

McCarthy Asset Management sold out of Merck (MRK) in Q2 2022, closing a stake of 360 shares — an estimated $30K sold.

McCarthy Asset Management first reported a position in MRK in Q1 2021 and held it in 5 quarters. The position peaked at $53K in Q2 2021. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

McCarthy Asset Management reported no remaining Merck position as of Q2 2022 after selling out during the quarter.
McCarthy Asset Management sold 360 Merck shares in Q2 2022, an estimated $30K.
McCarthy Asset Management first reported a position in Merck in Q1 2021 and held it in 5 quarters.
McCarthy Asset Management's Merck position peaked at $53K in Q2 2021.
3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on McCarthy Asset Management's 13F filing for Q2 2022, filed 20 Jul 2022.